Trial intelligence / Profile preview

Analgesic effect of esketamine in thoracoscopic pulmonary lobectomy

ChiCTR2200056524Phase 4Not yet recruiting

Sponsor
Jiangsu Provincial People's Hospital
Start
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine in acute postoperative pain (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Visual analogue scale of pain (calm breathing), Visual analogue scale of pain (deep cough) and 1 more. Planned start Feb 2022; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on ChiCTR2200056524.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200056524.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call